Industry / Poland

FDI Not Reaching Drug Industry

November 2007 | Industry News

Printable version
Bookmark

Record levels of foreign investment in the Polish economy should be having a positive impact on the country's pharmaceutical market. However,

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

Bioton And Polpharma Investigate Merger

Companies / Poland Polish pharmaceutical companies Bioton and Polpharma are to investigate the possibility of a merger. Bioton released a statement on November 17 2009 saying the companies had signed a letter of consent...

November 2009

Valeant Strengthens Dermatology Portfolio With Product Acquisitions

Industry / Poland US-based Valeant Pharmaceuticals International has signed an agreement to acquire several prescription and cosmetic dermatology products from an undisclosed privately-held Polish pharmaceutical company....

November 2009

PHF Begins Divestment

Industry / Poland The privatisation of pharmaceutical companies owned by Polish Pharmaceutical Holdings (PHF) - Polfa Pabianice, Polfa Tarchomin and Polfa Warszawa - looks set to become reality during late 2009 and early...

October 2009

DTP Distribution Model Under Threat

Industry / Poland AstraZeneca's direct-to-pharmacy (DTP) distribution system limits equal access to the drugmaker's products, Poland's Main Pharmaceutical Inspectorate (GIF) has said. The GIF said that the scheme contravenes...

October 2009

Government Restarts Privatisation Drive

Industry / Poland Poland's two leading domestic drug distributors Polish Pharmaceutical Group (PGF) and Farmacol are preparing to battle it out for state-owned wholesaler Cefarm Bialystock, which is to be privatised....

January 2008